Invest in 5,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. more
Time Frame | STIM | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.41% | 0.67% | 0.78% |
1-Month Return | -25% | 0.42% | 2.95% |
3-Month Return | -57.34% | 0.84% | 4.47% |
6-Month Return | -27.38% | 9.71% | 16.17% |
1-Year Return | -15.67% | 13.01% | 27.26% |
3-Year Return | -89.14% | 22.89% | 35.66% |
5-Year Return | -85.59% | 70.09% | 101.24% |
10-Year Return | -93.41% | 184.41% | 234.88% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 62.66M | 49.24M | 55.31M | 65.21M | 71.35M | [{"date":"2019-12-31","value":87.82,"profit":true},{"date":"2020-12-31","value":69.02,"profit":true},{"date":"2021-12-31","value":77.52,"profit":true},{"date":"2022-12-31","value":91.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 15.39M | 11.55M | 11.65M | 15.48M | 21.65M | [{"date":"2019-12-31","value":71.08,"profit":true},{"date":"2020-12-31","value":53.37,"profit":true},{"date":"2021-12-31","value":53.83,"profit":true},{"date":"2022-12-31","value":71.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 47.27M | 37.69M | 43.66M | 49.72M | 49.70M | [{"date":"2019-12-31","value":95.06,"profit":true},{"date":"2020-12-31","value":75.8,"profit":true},{"date":"2021-12-31","value":87.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.95,"profit":true}] |
Gross Margin | 75.44% | 76.54% | 78.93% | 76.26% | 69.66% | [{"date":"2019-12-31","value":95.57,"profit":true},{"date":"2020-12-31","value":96.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.61,"profit":true},{"date":"2023-12-31","value":88.25,"profit":true}] |
Operating Expenses | 74.20M | 60.00M | 71.22M | 84.83M | 80.25M | [{"date":"2019-12-31","value":87.46,"profit":true},{"date":"2020-12-31","value":70.73,"profit":true},{"date":"2021-12-31","value":83.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.6,"profit":true}] |
Operating Income | (26.93M) | (22.31M) | (27.56M) | (35.11M) | (30.55M) | [{"date":"2019-12-31","value":-2693000000,"profit":false},{"date":"2020-12-31","value":-2230900000,"profit":false},{"date":"2021-12-31","value":-2756400000,"profit":false},{"date":"2022-12-31","value":-3511100000,"profit":false},{"date":"2023-12-31","value":-3055400000,"profit":false}] |
Total Non-Operating Income/Expense | (5.80M) | (9.67M) | (7.65M) | (6.30M) | (5.04M) | [{"date":"2019-12-31","value":-579900000,"profit":false},{"date":"2020-12-31","value":-966600000,"profit":false},{"date":"2021-12-31","value":-764800000,"profit":false},{"date":"2022-12-31","value":-629900000,"profit":false},{"date":"2023-12-31","value":-503500000,"profit":false}] |
Pre-Tax Income | (29.04M) | (27.45M) | (31.19M) | (37.16M) | (30.19M) | [{"date":"2019-12-31","value":-2904400000,"profit":false},{"date":"2020-12-31","value":-2745300000,"profit":false},{"date":"2021-12-31","value":-3119300000,"profit":false},{"date":"2022-12-31","value":-3715900000,"profit":false},{"date":"2023-12-31","value":-3018900000,"profit":false}] |
Income Taxes | 5.26M | 4.82M | 4.41M | 2.05M | 1.00 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":91.78,"profit":true},{"date":"2021-12-31","value":83.89,"profit":true},{"date":"2022-12-31","value":38.96,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (34.30M) | (32.28M) | (35.60M) | (39.21M) | (30.19M) | [{"date":"2019-12-31","value":-3430000000,"profit":false},{"date":"2020-12-31","value":-3227700000,"profit":false},{"date":"2021-12-31","value":-3560200000,"profit":false},{"date":"2022-12-31","value":-3920700000,"profit":false},{"date":"2023-12-31","value":-3018900100,"profit":false}] |
Income From Continuous Operations | (29.04M) | (27.45M) | (31.19M) | (37.16M) | (30.16M) | [{"date":"2019-12-31","value":-2904400000,"profit":false},{"date":"2020-12-31","value":-2745300000,"profit":false},{"date":"2021-12-31","value":-3119300000,"profit":false},{"date":"2022-12-31","value":-3715900000,"profit":false},{"date":"2023-12-31","value":-3016500000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (34.30M) | (32.28M) | (35.60M) | (39.21M) | (30.19M) | [{"date":"2019-12-31","value":-3430000000,"profit":false},{"date":"2020-12-31","value":-3227700000,"profit":false},{"date":"2021-12-31","value":-3560200000,"profit":false},{"date":"2022-12-31","value":-3920700000,"profit":false},{"date":"2023-12-31","value":-3018900000,"profit":false}] |
EPS (Diluted) | (1.59) | (1.41) | (1.20) | (1.38) | (1.07) | [{"date":"2019-12-31","value":-159,"profit":false},{"date":"2020-12-31","value":-141,"profit":false},{"date":"2021-12-31","value":-120,"profit":false},{"date":"2022-12-31","value":-138,"profit":false},{"date":"2023-12-31","value":-107,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
STIM | |
---|---|
Cash Ratio | 3.35 |
Current Ratio | 5.65 |
Quick Ratio | 5.18 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
STIM | |
---|---|
ROA (LTM) | -15.37% |
ROE (LTM) | -72.48% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
STIM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.73 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.27 |
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. | 3.75 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
STIM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.80 |
P/B | 3.76 |
Price/FCF | NM |
EV/R | 1.83 |
EV/Ebitda | NM |
PEG | NM |
Director Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM)
An announcement from Neuronetics (STIM) is now available. Neuronetics, Inc. is set to share its financial and operational outlook at the upcoming W…
MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the William Blair 44 th Annual Growth Stock Conference on Thursday, June 6, 2024. The Company is scheduled to present at 10:00am Central Time the same day via webcast.
Neuronetics (NASDAQ: STIM ) just reported results for the first quarter of 2024. Neuronetics reported earnings per share of -27 cents. This was above the analyst estimate for EPS of -31 cents. The company reported revenue of $17.42 million. This was 1.73% better than the analyst estimate for revenue of $17.12 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.
Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses
Neuronetics Inc (STIM) has shared an update. Neuronetics, Inc. has updated its investor relations page with a fresh investor presentation and addit…
MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Neuronetics Inc. (STIM) on Tuesday reported a loss of $7.9 million in…
Neuronetics Inc (STIM) share price today is $1.83
Yes, Indians can buy shares of Neuronetics Inc (STIM) on Vested. To buy Neuronetics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in STIM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Neuronetics Inc (STIM) via the Vested app. You can start investing in Neuronetics Inc (STIM) with a minimum investment of $1.
You can invest in shares of Neuronetics Inc (STIM) via Vested in three simple steps:
The 52-week high price of Neuronetics Inc (STIM) is $5.07. The 52-week low price of Neuronetics Inc (STIM) is $1.03.
The price-to-earnings (P/E) ratio of Neuronetics Inc (STIM) is NM
The price-to-book (P/B) ratio of Neuronetics Inc (STIM) is 3.76
The dividend yield of Neuronetics Inc (STIM) is 0.00%
The market capitalization of Neuronetics Inc (STIM) is $54.90M
The stock symbol (or ticker) of Neuronetics Inc is STIM